Unsure Andy, you really do get so confused. You see there is a big difference between facts and interpretation. You may not agree with my interpretation but you have never contradicted any of my facts.
It was you, in fact, that was grossly inaccurate with your claims regarding SHV's debt levels - was it $90m you were out by? Even I don't think you were deliberately misleading, just confused ...
You claimed that my pointing out the March fall in almond price to $6.87 understated the price that SHV would get, when in fact they received a lower price. You and others also claimed that the March data was irrelevant as the almond price had subsequently recovered. Have you seen the most recent data indicating further falls in April?
You can put the most positive spin on every new data point but that doesn't make you right. All the evidence supports my original thesis, so we will have to wait for a management update to know who has made the correct interpretation.
- Forums
- ASX - By Stock
- SHV
- Almond Market Update
SHV
select harvests limited
Add to My Watchlist
0.97%
!
$4.07

Almond Market Update, page-44
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.07 |
Change
-0.040(0.97%) |
Mkt cap ! $578.3M |
Open | High | Low | Value | Volume |
$4.11 | $4.15 | $4.05 | $516.5K | 126.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 2489 | $4.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.13 | 8000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 739 | 4.060 |
2 | 1540 | 4.040 |
1 | 5000 | 4.030 |
2 | 2500 | 4.020 |
1 | 500 | 4.010 |
Price($) | Vol. | No. |
---|---|---|
4.180 | 200 | 1 |
4.190 | 1428 | 1 |
4.300 | 700 | 1 |
4.350 | 1999 | 1 |
4.480 | 20250 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
SHV (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online